Going further

Our team is driven by the desire to understand the human body. We believe there’s always something more to reveal, resulting in healthier, happier lives for us all.

Ashwin Pushpala
Ashwin Pushpala is the founder and CEO of Sano, the world’s first company to give people continuous and personalized insights into their body chemistry. Launching Sano five years ago, Ashwin hopes to see a world where everyone has access to their own biometric information, so they can make more thoughtful, proactive choices about their health. In 2017, he was named one of Forbes magazine’s “30 under 30” for his contributions in health and life sciences.

Ashwin was on the founding team of medical device company SinuSys after spending time at Bain Capital, where he invested in technology and semiconductor companies. Inspired by his parents’ work in the life science and semiconductor industries, Ashwin received a dual Bachelor’s degree in Bioengineering and Economics, and a Master’s in Bioengineering, from the University of Pennsylvania.
Phil Constantinou
VP, Product and Software
Phil Constantinou is VP of Product and Software at Sano, where he leads a multidisciplinary team of designers, data science, signal processing, firmware, web services, infrastructure, and app development engineers. Phil comes to Sano with deep experience in consumer software, hardware, as well as clinical information systems. He's driven by a desire to make lives better though thoughtfully crafted technology that's designed around human needs.

Phil has a degree in Computer Science from Stanford. Phil ran software development, design and product management at Evernote for seven years taking the product from 0 to over 200 million users. He's also built clinical information systems at Stanford School of Medicine and developed advanced consumer electronics.
Mark Mortellaro
VP, Sensor Development
Mark Mortellaro is VP of Sensor Development at Sano where he leads a team of scientists who are developing the core glucose sensing technology. He has two decades of experience in the medical device industry developing analyte sensors for in-vitro and in-vivo diagnostics. Mark has an aspiration to develop technologies that help people improve their health and lead better lives.

Mark comes to Sano from Senseonics where he directed chemistry R&D and watched the company grow from a small start-up to a commercial success with the launch of their long-term implantable glucose sensor, Eversense®. Prior to his tenure at Senseonics, Mark was a research scientist for AVL which became part of Roche Diagnostics. Mark has a Ph.D. in Chemistry from The Ohio State University.
Nicholas Mercer
Director, Hardware Engineering
Nic Mercer is the Director of Hardware Engineering, where he leads a team of ME and EE engineers and technicians. Nic joins Sano having just completed the successful development and scale up of the Calibra insulin delivery patch. The Calibra patch has been described by KOL within the diabetes community to be “a game changer” in the insulin delivery space given its slim, discrete, and customer focused design. Nic is deeply committed to being part of the modern wellness and prevention health movement and is confident that Sano’s minimally invasive technology will be a major part of it.

Nic brings over 20 years of product design, verification, and validation experience to the team which spans aerospace, cardiac, orthopedics, and diabetes. Nic has a bachelor degree in Mechanical Engineering from Vanderbilt University and a M.S. in Mechanical Engineering Design from Purdue University.
Matthew Chapman
Director, Research
Matthew Chapman is the Director of R&D at Sano, focusing on the development of Sano’s sensor technology. He lead a multidisciplinary team that uses electrochemistry, polymer chemistry, microfabrication, material science, and electrical engineering to develop and advance the capabilities of the platform. Matthew is excited about how access to real-time metabolic information will enable people to make better decisions—and drive discovery around human health and performance.

Matthew has an M.S. from the University of Chicago. Prior to joining Sano, he spent many years in academic research focusing on synthetic lipid membranes and protein interactions, super-resolution optical imaging, noninvasive prenatal diagnostics, and microfluidic technology at The University of Chicago, Baylor College of Medicine, and UC Berkeley.